Market Research Logo

EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report 2018

EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients Market Report 2018

This report studies the Active Pharmaceutical Ingredients market status and outlook of EMEA and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in EMEA and major countries, and splits the Active Pharmaceutical Ingredients market by product type and applications/end industries.

In the last several years, EMEA market of Active Pharmaceutical Ingredients developed rapidly, with an average growth rate of 9.46%. In 2017, Global Revenue of Active Pharmaceutical Ingredients is nearly 54000 M USD; the actual sales are about 9850 K MT.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Active Pharmaceutical Ingredients in these regions, from 2012 to 2025 (forecast), covering

Europe covers Germany, France, UK, Russia, Italy and Benelux;
Middle East includes Saudi Arabia, Israel, UAE and Iran;
Africa includes South Africa, Nigeria, Egypt and Algeria.

The major players in EMEA (Europe, Middle East and Africa) Active Pharmaceutical Ingredients market include
Teva
Mylan
DSM
Aurobindo Pharma
Aspen
Novartis
BASF
Pfizer
Huahai Pharmaceutical
Hisun Pharmaceutical
Sun Pharmaceutical Industries
Zhejiang Medicine
Dr. Reddy¡¯s Laboratories
Zhejiang NHU
Bayer
NCPC
AbbVie
Shandong Xinhua Pharmaceutical
Northeast Pharm
Harbin Pharmaceutical
LKPC

On the basis of product, the Active Pharmaceutical Ingredients market is primarily split into
Synthetic APIs
Biotech APIs

On the basis on the end users/applications, this report covers
CNS
Cardiovascular
Genitourinary/Hormonal Drugs
Respiratory
Rheumatology
Diabetes
Oncology
Others


1 Active Pharmaceutical Ingredients Overview
1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients by Product Category
1.2.1 EMEA Active Pharmaceutical Ingredients Sales Comparison by Types (2012-2025)
1.2.2 EMEA Active Pharmaceutical Ingredients Sales Market Share by Types in 2017
1.2.3 Synthetic APIs
1.2.4 Biotech APIs
1.3 EMEA Active Pharmaceutical Ingredients Market by Applications/End Users
1.3.1 EMEA Active Pharmaceutical Ingredients Sales and CAGR Comparison by Applications (2012-2025)
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.4 EMEA Active Pharmaceutical Ingredients Market Overview by Regions
1.4.1 EMEA Active Pharmaceutical Ingredients Revenue Comparison by Regions (2012-2025)
1.4.2 Europe Active Pharmaceutical Ingredients Status and Prospect (2012-2025)
1.4.3 Middle East Active Pharmaceutical Ingredients Status and Prospect (2012-2025)
1.4.4 Africa Active Pharmaceutical Ingredients Status and Prospect (2012-2025)
1.5 EMEA Market Size (Sales and Revenue) of Active Pharmaceutical Ingredients (2012-2025)
1.5.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2025)
1.5.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2025)
2 EMEA Active Pharmaceutical Ingredients Competition by Manufacturers/Players/Suppliers, Regions, Type and Application
2.1 EMEA Active Pharmaceutical Ingredients Market Competition by Players/ Manufacturers
2.1.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share of Major Players (2016-2017)
2.1.2 EMEA Active Pharmaceutical Ingredients Revenue (M USD) and Market Share (%) by Players (2016-2017)
2.1.3 EMEA Active Pharmaceutical Ingredients Sale Price by Players (2016-2017)
2.2 EMEA Active Pharmaceutical Ingredients Sales and Revenue by Type/Product Category
2.2.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share (%) by Type (2012-2017)
2.2.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Active Pharmaceutical Ingredients Sale Price by Type (2012-2017)
2.3 EMEA Active Pharmaceutical Ingredients (Volume) by Application
2.4 EMEA Active Pharmaceutical Ingredients Sales and Revenue by Regions
2.4.1 EMEA Active Pharmaceutical Ingredients Sales and Market Share by Regions (2012-2017)
2.4.2 EMEA Active Pharmaceutical Ingredients Revenue and Market Share by Regions (2012-2017)
2.4.3 EMEA Active Pharmaceutical Ingredients Sales Price by Regions (2012-2017)
3 Europe Active Pharmaceutical Ingredients (Sales, Revenue), Countries, Type and Application
3.1 Europe Active Pharmaceutical Ingredients Sales and Revenue (2012-2017)
3.1.1 Europe Active Pharmaceutical Ingredients Sales and Growth Rate (2012-2017)
3.1.2 Europe Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
3.2 Europe Active Pharmaceutical Ingredients Sales and Market Share by Type
3.3 Europe Active Pharmaceutical Ingredients Sales and Market Share by Applications
3.4 Europe Active Pharmaceutical Ingredients Sales and Revenue by Countries
3.4.1 Europe Active Pharmaceutical Ingredients Sales by Countries (2012-2017)
3.4.2 Europe Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
3.4.3 Germany Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
3.4.4 France Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
3.4.5 UK Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
3.4.6 Russia Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
3.4.7 Italy Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
3.4.8 Benelux Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
4 Middle East Active Pharmaceutical Ingredients (Sales, Revenue), Countries, Type and Application
4.1 Middle East Active Pharmaceutical Ingredients Sales and Revenue (2012-2017)
4.1.1 Middle East Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
4.1.2 Middle East Active Pharmaceutical Ingredients Revenue and Growth Rate (2012-2017)
4.2 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Type
4.3 Middle East Active Pharmaceutical Ingredients Sales and Market Share by Applications
4.4 Middle East Active Pharmaceutical Ingredients Sales and Revenue by Countries (2012-2017)
4.4.1 Middle East Active Pharmaceutical Ingredients Sales by Countries (2012-2017)
4.4.2 Middle East Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
4.4.4 Israel Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
4.4.5 UAE Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
4.4.6 Iran Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
5 Africa Active Pharmaceutical Ingredients (Sales, Revenue), Countries, Type and Application
5.1 Africa Active Pharmaceutical Ingredients Sales and Revenue (2012-2017)
5.1.1 Africa Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
5.1.2 Africa Active Pharmaceutical Ingredients Revenue and Growth Rate (%) (2012-2017)
5.2 Africa Active Pharmaceutical Ingredients Sales and Market Share by Type
5.3 Africa Active Pharmaceutical Ingredients Sales and Market Share by Applications
5.4 Africa Active Pharmaceutical Ingredients Sales and Revenue by Countries (2012-2017)
5.4.1 Africa Active Pharmaceutical Ingredients Sales by Countries (2012-2017)
5.4.2 Africa Active Pharmaceutical Ingredients Revenue by Countries (2012-2017)
5.4.3 South Africa Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
5.4.4 Nigeria Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
5.4.5 Egypt Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
5.4.6 Algeria Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
6 EMEA Active Pharmaceutical Ingredients Manufacturers/Players Profiles and Sales Data
6.1 Teva
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Cost, Gross, and Revenue
6.2 Mylan
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Cost, Gross, and Revenue
6.3 DSM
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Cost, Gross, and Revenue
6.4 Aurobindo Pharma
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Cost, Gross, and Revenue
6.5 Aspen
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Cost, Gross, and Revenue
6.6 Novartis
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Cost, Gross, and Revenue
6.7 BASF
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Cost, Gross, and Revenue
6.8 Pfizer
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Sales, Price, Cost, Gross, and Revenue
6.9 Huahai Pharmaceutical
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Sales, Price, Cost, Gross, and Revenue
6.10 Hisun Pharmacy
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Sales, Price, Cost, Gross, and Revenue
6.11 Sun Pharmaceutical Industries
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Sales, Price, Cost, Gross, and Revenue
6.12 Zhejiang Medicine
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Sales, Price, Cost, Gross, and Revenue
6.13 Dr. Reddy¡¯s Laboratories
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Sales, Price, Cost, Gross, and Revenue
6.14 Zhejiang NHU
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Sales, Price, Cost, Gross, and Revenue
6.15 Bayer
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Sales, Price, Cost, Gross, and Revenue
6.16 NCPC
6.16.1 Company Profile
6.16.2 Product Information
6.16.3 Sales, Price, Cost, Gross, and Revenue
6.17 AbbVie
6.17.1 Company Profile
6.17.2 Product Information
6.17.3 Sales, Price, Cost, Gross, and Revenue
6.18 Shandong Xinhua Pharmaceutical
6.18.1 Company Profile
6.18.2 Product Information
6.18.3 Sales, Price, Cost, Gross, and Revenue
6.19 Northeast Pharm
6.19.1 Company Profile
6.19.2 Product Information
6.19.3 Sales, Price, Cost, Gross, and Revenue
6.20 Harbin Pharmaceutical
6.20.1 Company Profile
6.20.2 Product Information
6.20.3 Sales, Price, Cost, Gross, and Revenue
6.21 LKPC
6.21.1 Company Profile
6.21.2 Product Information
6.21.3 Sales, Price, Cost, Gross, and Revenue
7 New Drugs Manufacturing Cost Analysis
7.1 New Drugs R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 New requirements for active pharmaceutical ingredients imported into the European Economic Area by Grant Strachan
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Active Pharmaceutical Ingredients Market Forecast (2018-2025)
11.1 EMEA Active Pharmaceutical Ingredients Sales, Revenue Forecast (2018-2025)
11.1.1 EMEA Active Pharmaceutical Ingredients Sales and Growth Rate Forecast (2018-2025)
11.1.2 EMEA Active Pharmaceutical Ingredients Revenue and Growth Rate Forecast (2018-2025)
11.2 EMEA Active Pharmaceutical Ingredients Sales and Revenue and Growth Rate Forecast by Regions (2018-2025)
11.3 Europe Active Pharmaceutical Ingredients Sales and Revenue and Growth Rate (%) Forecast by Regions (2018-2025)
11.4 Middle East Active Pharmaceutical Ingredients Sales and Revenue and Growth Rate Forecast by Regions (2018-2025)
11.5 Africa Active Pharmaceutical Ingredients Sales and Revenue and Growth Rate Forecast by Regions (2018-2025)
11.6 EMEA Active Pharmaceutical Ingredients Sales Forecast by Type (2018-2025)
11.7 EMEA Active Pharmaceutical Ingredients Sales Forecast by Application (2018-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Active Pharmaceutical Ingredients
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) Market Split by Product Type
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Types in 2017
Figure Synthetic APIs Product Picture
Figure Biotech APIs Product Picture
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) by Application (2018-2025)
Figure EMEA Sales Market Share (%) of Active Pharmaceutical Ingredients by Applications in 2017
Figure CNS Examples
Figure Cardiovascular Examples
Figure Genitourinary/Hormonal Drugs Examples
Figure Respiratory Examples
Figure Rheumatology Examples
Figure Diabetes Examples
Figure Oncology Examples
Table EMEA Market Active Pharmaceutical Ingredients Revenue (M USD) Comparison by Regions 2012-2025
Figure Europe Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (2012-2025)
Figure Middle East Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (2012-2025)
Figure Africa Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (2012-2025)
Figure EMEA Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2025)
Figure EMEA Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (2012-2025)
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) of Major Players (2016-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Players (2016-2017)
Figure 2016 Active Pharmaceutical Ingredients Sales Market Share (%) by Players
Figure 2017 Active Pharmaceutical Ingredients Sales Market Share (%) by Players
Table EMEA Active Pharmaceutical Ingredients Revenue (M USD) by Players (2016-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) by Players (2016-2017)
Table 2016 EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) by Players
Table 2017 EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) by Players
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/MT) by Players (2016-2017)
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) and Market Share (%) by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Type (2012-2017)
Figure Sales Market Share (%) of Active Pharmaceutical Ingredients by Type (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Type in 2017
Table EMEA Active Pharmaceutical Ingredients Revenue (M USD) and Market Share (%) by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) by Type (2012-2017)
Figure Revenue Market Share (%) of Active Pharmaceutical Ingredients by Type in 2012-2017
Table EMEA Active Pharmaceutical Ingredients Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) and Market Share (%) by Application (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Application (2012-2017)
Figure Sales Market Share (%) of Active Pharmaceutical Ingredients by Application (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Application in 2017
Table EMEA Active Pharmaceutical Ingredients Sales (K MT) and Market Share (%) by Regions (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Sales Market Share (%) by Regions (2012-2017)
Figure Sales Market Share (%) of Active Pharmaceutical Ingredients by Regions (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Sales Market Share (%) in 2017
Table EMEA Active Pharmaceutical Ingredients Revenue (M USD) and Market Share (%) by Regions (2012-2017)
Table EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) by Regions (2012-2017)
Figure Revenue Market Share (%) of Active Pharmaceutical Ingredients by Regions (2012-2017)
Figure EMEA Active Pharmaceutical Ingredients Revenue Market Share (%) Regions in 2017
Table EMEA Active Pharmaceutical Ingredients Sales Price (USD/MT) by Regions (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (%) (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales (K MT) by Type (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Market Share (%) by Type (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share (%) by Type in 2017
Table Europe Active Pharmaceutical Ingredients Sales (K MT) by Applications (2012-2017)
Table Europe Active Pharmaceutical Ingredients Market Share (%) by Applications (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Market Share (%) by Applications in 2017
Table Europe Active Pharmaceutical Ingredients Sales (K MT) by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Sales Market Share (%) by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share (%) by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Sales Market Share (%) by Countries in 2017
Table Europe Active Pharmaceutical Ingredients Revenue (M USD) by Countries (2012-2017)
Table Europe Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Europe Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries in 2017
Figure Germany Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure France Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure UK Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Russia Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Italy Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Benelux Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales and Growth Rate (%) (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (%) (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Sales (K MT) by Type (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Market Share (%) by Type (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Market Share (%) by Type in 2017
Table Middle East Active Pharmaceutical Ingredients Sales (K MT) by Applications (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Market Share (%) by Applications (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share (%) by Application in 2017
Table Middle East Active Pharmaceutical Ingredients Sales (K MT) by Countries (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Sales Market Share (%) by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share (%) by Countries in (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Sales Market Share (%) by Countries in 2017
Table Middle East Active Pharmaceutical Ingredients Revenue (M USD) by Countries (2012-2017)
Table Middle East Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Middle East Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries in 2017
Figure Saudi Arabia Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Israel Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure UAE Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Iran Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue (M USD) and Growth Rate (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales (K MT) by Type (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Type (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Type in 2017
Table Africa Active Pharmaceutical Ingredients Sales (K MT) by Applications (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Applications (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Applications in 2017
Table Africa Active Pharmaceutical Ingredients Sales (K MT) by Countries (2012-2017)
Table Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Sales Market Share (%) by Countries in 2017
Table Africa Active Pharmaceutical Ingredients Revenue (M USD) by Countries (2012-2017)
Table Africa Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries (2012-2017)
Figure Africa Active Pharmaceutical Ingredients Revenue Market Share (%) by Countries in 2017
Figure South Africa Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Nigeria Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Egypt Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Figure Algeria Active Pharmaceutical Ingredients Sales (K MT) and Growth Rate (%) (2012-2017)
Table Teva Company Profile
Table Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Teva 2016-2017
Table Mylan Company Profile
Table Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Mylan 2016-2017
Table DSM Company Profile
Table Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of DSM 2016-2017
Table Aurobindo Pharma Company Profile
Table Active Pharmaceutical Ingredients Sales (K MT), Price (USD/MT), Cost (USD/MT), Gross (USD/MT), Revenue (M USD) and Gross Margin of Aurobindo Pharma 2016-2017
Table Aspen Company Profile

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report